CDKN2B and gastric cancer: In conclusion, the current findings reveal that p16, CDH1, RUNX3, MLH1, RASSF1A, p15, APC, GSTP1, Reprimo, or MGMTpromoter methylation is associated with blood samples of patients with GC.